# K173441: Neurosoft TMS (also CloudTMS)

- Pathway: 510(k) (Special)
- Applicant: Teleemg, LLC
- Decided: Dec 13, 2017 after 37 days
- Product code: OBP (Transcranial Magnetic Stimulator)
- Device class: 2
- Regulation: 21 CFR 882.5805
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 6 generations back to DEN070003 (2008). 9 ancestors in all.
17 later devices descend from it; 4 cite it directly.
0 of 27 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K160309: Neurosoft TMS, Teleemg, LLC (2016) Summary page 4.
- K171481: MagVita TMS Therapy System, Tonica Elektronik A/S (2017) Summary page 4.

## Most influential descendants
- K180907: HORIZON TMS Therapy System (2018), 12 descendants of its own
- K182853: HORIZON TMS Therapy System (2019), 10 descendants of its own
- K183376: HORIZON TMS Therapy System with Navigation (2019), 7 descendants of its own
- K211389: Magstim Horizon 3.0 TMS Therapy System, Horizon 3.0 System, Horizon 3.0, Horizon 3.0 with Navigation (2021), 6 descendants of its own
- K222171: Magstim Horizon 3.0 TMS Therapy System, Horizon 3.0 System, Horizon 3.0, H3.0, Horizon 3.0 with StimGuide+ (2023), 4 descendants of its own

## Indications for use
The Neurosoft TMS is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode.

Source page: https://510kreport.com/device/K173441
Methodology: https://510kreport.com/methodology